MetAL trial for prostate cancer
1 Jul 2016
MetAL trial for prostate cancer
Modelling ponatinib resistance in BCR-ABL1 cell lines
Genomic interrogation of tumour samples reveals essential targets
Screening and early detection of cervical cancer in Africa
Halving cancer mortality
Systems perspectives of the exposome
Tackling cancer in the developing world
Editor's Choice for June 2016
Mutations associated with imatinib response in CML
Editor's ASCO 2016 Roundup
Inpatient palliative care intervention in patients hospitalized for HSCT
Latest in precision cancer medicine